Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230347 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00230347: Completed Phase 1 study, sponsored by Stanford University.
NCT00230347 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00230347, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is intended to establish the practicality of treating cancer in the liver with precisely administered single fractions of high-energy radiation using a radiosurgical (cross-firing) technique. A second purpose is to establish a safe dose for such therapy. Finally, the efficacy of radiosurgical ablation of liver tumors, in terms of radiographic response, will be measured.
Interventions
- PROCEDURE Stereotactic radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-10 |
| Est. Completion | 2007-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00230347
The ClinicalTrials.gov registry entry for NCT00230347 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic radiosurgery is the first listed.
NCT00230347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00230347 about?
NCT00230347 is a clinical study titled "Evaluation of Stereotactic Radiosurgery For Liver Malignancies". This study is intended to establish the practicality of treating cancer in the liver with precisely administered single fractions of high-energy radiation using a radiosurgical (cross-firing) technique. A second purpose is to establish a safe dose for such therapy. Finally, the efficacy of radiosurg...
What is the current status of trial NCT00230347?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2003-10. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00230347?
The interventions under investigation include: Stereotactic radiosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00230347?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.